Literature DB >> 20307613

Peripherally injected CCK-8S activates CART positive neurons of the paraventricular nucleus in rats.

Lisa Peter1, Andreas Stengel2, Steffen Noetzel1, Tobias Inhoff1, Miriam Goebel2, Yvette Taché2, Rüdiger W Veh3, Norbert Bannert4, Carsten Grötzinger1, Bertram Wiedenmann1, Burghard F Klapp5, Hubert Mönnikes6, Peter Kobelt1,5.   

Abstract

Cholecystokinin (CCK) plays a role in the short-term inhibition of food intake. Cocaine- and amphetamine-regulated transcript (CART) peptide has been observed in neurons of the paraventricular nucleus (PVN). It has been reported that intracerebroventricular injection of CART peptide inhibits food intake in rodents. The aim of the study was to determine whether intraperitoneally (ip) injected CCK-8S affects neuronal activity of PVN-CART neurons. Ad libitum fed male Sprague-Dawley rats received 6 or 10 microg/kg CCK-8S or 0.15M NaCl ip (n=4/group). The number of c-Fos-immunoreactive neurons was determined in the PVN, arcuate nucleus (ARC), and the nucleus of the solitary tract (NTS). CCK-8S dose-dependently increased the number of c-Fos-immunoreactive neurons in the PVN (mean+/-SEM: 102+/-6 vs. 150+/-5 neurons/section, p<0.05) and compared to vehicle treated rats (18+/-7, p<0.05 vs. 6 and 10 microg/kg CCK-8S). CCK-8S at both doses induced an increase in the number of c-Fos-immunoreactive neurons in the NTS (65+/-13, p<0.05, and 182+/-16, p<0.05). No effect on the number of c-Fos neurons was observed in the ARC. Immunostaining for CART and c-Fos revealed a dose-dependent increase of activated CART neurons (19+/-3 vs. 29+/-7; p<0.05), only few activated CART neuron were observed in the vehicle group (1+/-0). The present observation shows that CCK-8S injected ip induces an increase in neuronal activity in PVN-CART neurons and suggests that CART neurons in the PVN may play a role in the mediation of peripheral CCK-8S's anorexigenic effects. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307613      PMCID: PMC4040251          DOI: 10.1016/j.peptides.2010.03.013

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  43 in total

1.  Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats.

Authors:  B R Olson; M D Drutarosky; M S Chow; V J Hruby; E M Stricker; J G Verbalis
Journal:  Peptides       Date:  1991 Jan-Feb       Impact factor: 3.750

2.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Cholecystokinin elicits satiety in rats with open gastric fistulas.

Authors:  J Gibbs; R C Young; G P Smith
Journal:  Nature       Date:  1973-10-12       Impact factor: 49.962

Review 4.  Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins.

Authors:  J F Rehfeld; H F Hansen; P D Marley; K Stengaard-Pedersen
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

5.  Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats.

Authors:  S A Stanley; C J Small; K G Murphy; E Rayes; C R Abbott; L J Seal; D G Morgan; D Sunter; C L Dakin; M S Kim; R Hunter; M Kuhar; M A Ghatei; S R Bloom
Journal:  Brain Res       Date:  2001-03-02       Impact factor: 3.252

6.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

7.  Co-localization of cart peptide immunoreactivity and nitric oxide synthase activity in rat hypothalamus.

Authors:  E O Koylu; E Weruaga; B Balkan; J R Alonso; M J Kuhar; S Pogun
Journal:  Brain Res       Date:  2000-06-23       Impact factor: 3.252

8.  Tachykinin neurokinin 3 receptor signaling in cholecystokinin-elicited release of oxytocin and vasopressin.

Authors:  Gwendolen E Haley; Francis W Flynn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-02       Impact factor: 3.619

9.  Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system.

Authors:  L I Larsson; J F Rehfeld
Journal:  Brain Res       Date:  1979-04-13       Impact factor: 3.252

10.  Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects.

Authors:  D D Krahn; B A Gosnell; A S Levine; J E Morley
Journal:  Brain Res       Date:  1988-03-08       Impact factor: 3.252

View more
  7 in total

1.  Cocaine- and amphetamine-regulated transcript is the neurotransmitter regulating the action of cholecystokinin and leptin on short-term satiety in rats.

Authors:  Andrea Heldsinger; Yuanxu Lu; Shi-Yi Zhou; Xiaoyin Wu; Gintautas Grabauskas; Il Song; Chung Owyang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-30       Impact factor: 4.052

Review 2.  Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Protein Pept Sci       Date:  2011-06       Impact factor: 3.272

3.  Sulfated cholecystokinin-8 activates phospho-mTOR immunoreactive neurons of the paraventricular nucleus in rats.

Authors:  Vanessa Lembke; Miriam Goebel; Lisa Frommelt; Tobias Inhoff; Reinhardt Lommel; Andreas Stengel; Yvette Taché; Carsten Grötzinger; Norbert Bannert; Bertram Wiedenmann; Burghard F Klapp; Peter Kobelt
Journal:  Peptides       Date:  2010-10-07       Impact factor: 3.750

4.  Ectopic expression of Irx3 and Irx5 in the paraventricular nucleus of the hypothalamus contributes to defects in Sim1 haploinsufficiency.

Authors:  Joe Eun Son; Zhengchao Dou; Siyi Wanggou; Jade Chan; Rong Mo; Xuejun Li; Xi Huang; Kyoung-Han Kim; Jacques L Michaud; Chi-Chung Hui
Journal:  Sci Adv       Date:  2021-10-27       Impact factor: 14.136

5.  Involvement of prolactin-releasing peptide in the activation of oxytocin neurones in response to food intake.

Authors:  M Yamashita; Y Takayanagi; M Yoshida; K Nishimori; M Kusama; T Onaka
Journal:  J Neuroendocrinol       Date:  2013-05       Impact factor: 3.627

6.  Insulin Activates Vagal Afferent Neurons Including those Innervating Pancreas via Insulin Cascade and Ca(2+) Influx: Its Dysfunction in IRS2-KO Mice with Hyperphagic Obesity.

Authors:  Yusaku Iwasaki; Kenju Shimomura; Daisuke Kohno; Katsuya Dezaki; Enkh-Amar Ayush; Hajime Nakabayashi; Naoto Kubota; Takashi Kadowaki; Masafumi Kakei; Masanori Nakata; Toshihiko Yada
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

7.  Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice.

Authors:  Z Pirník; L Kořínková; J Osacká; B Železná; J Kuneš; L Maletínská
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.